Can a simple score help doctors complete Small-Bowel scopes?

NCT ID NCT07288346

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a predictive model before a double-balloon enteroscopy helps doctors fully examine the small intestine. About 338 adults with suspected small-bowel disease will be randomly assigned to have their doctor see the model score or not. The main goal is to see if the model increases the rate of complete small-bowel visualization.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
predictive model
What this could lead to
If it works, this could help doctors plan small-bowel exams more effectively, potentially reducing procedure time and improving success rates.
What could go wrong
This is a small, early-stage study focused on a procedural tool, not a treatment. The model may not improve outcomes or may not be widely applicable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DOUBLE-BALLOON ENTEROSCOPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dezhou People's Hospital

    RECRUITING

    Dezhou, Shandong, China

  • Qilu Hospital of Shandong University

    RECRUITING

    Jinan, Shangdong, China

  • Qilu Hospital of Shandong University (Qingdao)

    RECRUITING

    Qingdao, Shandong, China

  • Yantai Affiliated Hospital of Binzhou Medical University

    RECRUITING

    Yantai, Shandong, China

  • Zaozhuang Municipal Hospital

    RECRUITING

    Zaozhuang, Shandong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.